Table 1.
Demographic parameters in SARI patients with and without COVID-19
| Demographic parameter | Total (n = 167) |
SARI patients with COVID-19 (Group 1, n = 28) |
SARI patients without Covid-19 (Group 2, n = 139) |
p value |
|---|---|---|---|---|
| Age (years) | ||||
| < 12 | 23 (13.7%) | 2 (7.1%) | 21 (15.1%) | 0.309 |
| 12–40 | 43 (25.7%) | 5 (17.8%) | 38 (27.3%) | |
| 41–60 | 45 (26.9%) | 8 (28.5%) | 37 (26.6%) | |
| ≥ 61 | 55 (32.9%) | 13 (46.4%) | 43 (30.9%) | |
| Gender | ||||
| Male | 101 (60.4%) | 17 (60.7%) | 84 (60.4%) | 0.978 |
| Female | 66 (39.5%) | 11 (39.28%) | 55 (39.5%) | |
| Symptoms | ||||
| Cough | 119 (71.2%) | 20 (71.4%) | 99 (71.2%) | 0.206 |
| Fever | 106 (63.4%) | 17 (60.7%) | 89 (64.0%) | |
| Sore throat | 45 (26.9%) | 9 (32.14%) | 36 (25.8%) | |
| Chest pain | 8 (4.7%) | 1 (3.5%) | 7 (5.0%) | |
| Abdominal pain | 15 (8.9%) | 1 (3.5%) | 14 (10.0%) | |
| Diarrhoea | 10 (5.9%) | 2 (7.1%) | 8 (5.7%) | |
| Nausea | 7 (4.1%) | 2 (7.1%) | 5 (3.5%) | |
| Body ache | 25 (14.9%) | 5 (17.8%) | 20 (14.3%) | |
| Sputum | 31 (18.5%) | 2 (7.1%) | 29 (20.3%) | |
| Vomiting | 7 (4.1%) | 0 (0%) | 7 (5.0%) | |
| Haemoptysis | 4 (2.3%) | 2 (7.1%) | 2 (1.4%) | |
| Nasal discharge | 8 (4.7%) | 1 (3.5%) | 7 (5.9%) | |
| Breathlessness | 133 (79.6%) | 23 (82.14%) | 110 (79.1%) | |
*p value < 0.05-Significant